These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 26333655)
1. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Felker GM; Mentz RJ; Teerlink JR; Voors AA; Pang PS; Ponikowski P; Greenberg BH; Filippatos G; Davison BA; Cotter G; Prescott MF; Hua TA; Lopez-Pintado S; Severin T; Metra M Eur J Heart Fail; 2015 Dec; 17(12):1262-70. PubMed ID: 26333655 [TBL] [Abstract][Full Text] [Related]
2. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR; J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292 [TBL] [Abstract][Full Text] [Related]
3. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185 [TBL] [Abstract][Full Text] [Related]
4. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial. Pang PS; Teerlink JR; Voors AA; Ponikowski P; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Kriger J; Prescott MF; Hua TA; Severin T; Metra M JACC Heart Fail; 2016 Jul; 4(7):591-599. PubMed ID: 27039129 [TBL] [Abstract][Full Text] [Related]
5. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M; Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816 [TBL] [Abstract][Full Text] [Related]
6. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Masson S; Anand I; Favero C; Barlera S; Vago T; Bertocchi F; Maggioni AP; Tavazzi L; Tognoni G; Cohn JN; Latini R; Circulation; 2012 Jan; 125(2):280-8. PubMed ID: 22139751 [TBL] [Abstract][Full Text] [Related]
7. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908 [TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J; Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025 [TBL] [Abstract][Full Text] [Related]
9. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study. Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872 [TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification. de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483 [TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. Cotter G; Voors AA; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Milo O; Hua TA; Qian M; Severin TM; Teerlink JR; Metra M; Davison BA Eur J Heart Fail; 2015 Nov; 17(11):1133-43. PubMed ID: 26333529 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease. Biener M; Giannitsis E; Lamerz J; Mueller-Hennessen M; Vafaie M; Katus HA Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):409-418. PubMed ID: 26450785 [TBL] [Abstract][Full Text] [Related]
13. Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure. Zymliński R; Sokolski M; Siwolowski P; Biegus J; Nawrocka S; Jankowska EA; Todd J; Yerramilli R; Estis J; Banasiak W; Ponikowski P Int J Cardiol; 2017 Mar; 230():646-652. PubMed ID: 28069251 [TBL] [Abstract][Full Text] [Related]
14. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [TBL] [Abstract][Full Text] [Related]
16. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death. McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107 [TBL] [Abstract][Full Text] [Related]
17. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953 [TBL] [Abstract][Full Text] [Related]
18. Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study. Felker GM; Teerlink JR; Butler J; Hernandez AF; Miller AB; Cotter G; Davison BA; Filippatos G; Greenberg BH; Ponikowski P; Voors AA; Hua TA; Severin TM; Unemori E; Metra M J Am Coll Cardiol; 2014 Oct; 64(15):1591-8. PubMed ID: 25301463 [TBL] [Abstract][Full Text] [Related]
19. Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents. Cardinaels EP; Daamen MA; Bekers O; ten Kate J; Niens M; van Suijlen JD; van Dieijen-Visser MP; Brunner-La Rocca HP; Schols JM; Mingels AM J Am Med Dir Assoc; 2015 Oct; 16(10):884-91. PubMed ID: 26255708 [TBL] [Abstract][Full Text] [Related]
20. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. McQueen MJ; Kavsak PA; Xu L; Shestakovska O; Yusuf S Clin Biochem; 2013 Jan; 46(1-2):5-9. PubMed ID: 23063983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]